Delivery Order 75N95024D00023-75N95024F00001

Sri International has been awarded a $4,446 delivery order against the PREVENT Preclinical Drug Development Program multiple award IDIQ by the National Cancer Institute. The delivery order is to fund a prevent contract orientation and kick-off meeting, which will provide an overview and launch the preclinical toxicology and pharmacology testing services available under the PREVENT program vehicle. Sri International will perform the work as prime contractor, with all services taking place in West...

The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $503,901 Delivery Order to Sri International under the Pharmacology and Toxicology for Therapeutics Program Indefinite Delivery Indefinite Quantity master contract. Sri International will provide Follow-On Studies - Ind-Enabling GLP Toxicology from its West Menlo Park, California location between September 2022 and September 2024. Charles River...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $268,799.00 delivery order contract to Sri International for non-clinical safety assessment of ORC-13661 to support aminoglycoside induced hearing loss indication. Sri International will perform the work as the prime contractor in West Menlo Park, California from September 14, 2022 through November 13, 2023. Bioivt, LLC will serve as a subcontractor providing a...

Sri International has been awarded a cost-plus-fixed-fee delivery order valued at $571,190 by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), to conduct Task Order 01 for Cocaine Interaction Safety Studies in Rats under the Toxicological Evaluations of Potential Medications IDIQ. The ordering period is from September 12, 2023 through September 11, 2024. The place of performance is West Menlo Park, California. No set-aside designation...

This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to SRI International, a non-profit research institute, for a suite of GLP toxicology studies under the Pharmacology and Toxicology for Therapeutics Program (PTTP) indefinite delivery, indefinite quantity (IDIQ) contract. The contract has a potential value of $2,149,530.00 and a completion date of May 31, 2021. It is not designated as a set-aside...

This is a $1,010.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for a "Kick Off Meeting, Preclinical Pharmacokinetic & Pharmacology Evaluations of Agents Being Developed for Cancer Patients" with a performance period from July 1, 2016 to September 30, 2016. This work is being performed under NCI's Pharmacokinetic and Pharmacology Evaluations for...

Sri International has been awarded a delivery order against the PREVENT Preclinical Drug Development Program (PREVENT) multiple award contract vehicle to provide orientation and kick-off meeting services for the PREVENT contract. This $4,863 cost-plus-fixed-fee order was issued by the National Cancer Institute, a component of the Department of Health and Human Services, and will be performed in West Menlo Park, California with a period of performance from January 25, 2019 through February 24,...

This is a Cost Plus Fixed Fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the non-profit research institute SRI International. The $3,919,858.62 task order is for a 39-week oral toxicology and toxicokinetic study in mature cynomolgus monkeys with the drug candidate PA-824, with a 12-week recovery period. This work falls under NIAID's broader "Preclinical Services for the Development...

This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The contract is for "PRECLINICAL PHARMACOLOGY AND TOXICOLOGY STUDIES - CONTRACT ORIENTATION MEETING WITH NCI, OFFICE OF ACQUISITIONS" and is part of a larger Preclinical Pharmacology and Toxicology Studies 2012-2014 contract vehicle. The award has a ceiling value of $4,010...

This is a Cost Plus Fixed Fee delivery order awarded by the National Institutes of Health (NIH), National Institute on Drug Abuse to SRI International, a non-profit research institute. The contract is for IND-enabling Good Laboratory Practice (GLP) toxicology studies under the Pharmacology and Toxicology for Therapeutics Program (PTTP) Indefinite Delivery, Indefinite Quantity (IDIQ) master contract. The potential value of this particular delivery order is $1,759,706.00, with a completion date of...